Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis
The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Stimulants used to treat attention-deficit/hyperactivity disorder (ADHD) have been well researched, but comparisons among stimulants are hindered by the absence of direct comparative trials. The goal of this work was to compare the efficacy of methylphenidate and amfetamine formulations through a meta-analysis of double-blind placebo-controlled trials. We analyzed recent published literature on the stimulant therapy of ADHD to describe the variability of drug-placebo effect sizes. A literature search was conducted to identify double-blind, placebo-controlled studies of ADHD in children and adolescents published after 1979. Meta-analysis regression assessed the influence of medication type and study design features on medication effects. Twenty-three trials met criteria and were included in this meta-analysis. These trials studied 11 drugs using 19 different outcome measures of hyperactive, inattentive, or impulsive behavior. We found significant differences between amfetamine and methylphenidate products, even after correcting for study design features that might have confounded the results. Our analyses indicate that effect sizes for amfetamine products are significantly, albeit moderately, greater than those for methylphenidate. We found that most measures of effect from all studies were statistically significant. Our findings suggest that amfetamine products may be moderately more efficacious than methylphenidate products, even after controlling for potentially confounding…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Meta-analyses have demonstrated that stimulant and non-stimulant medications for ADHD effectively reduce ADHD symptoms inchildren and adults 142,143 .”
From Attention-deficit/hyperactivity disorder (2015) · cites this paper as [143]
In the citing paper
“some patients preferentially respond to and tolerate one or the other 143 .”
From Attention-deficit/hyperactivity disorder (2015) · cites this paper as [143]
In the citing paper
“Although the efficacy of both classes of stimulants is similar”
From Attention-deficit/hyperactivity disorder (2015) · cites this paper as [143]
In the citing paper
“It has been speculated that the moderately greater efficacy of AMP-based agents compared with MPH-based agents in ADHD may be related to differences in their molecular actions (33), but to date there is no conclusive clinical evidence to support this speculation.”
In the citing paper
“It is noteworthy that medications for ADHD operate by altering the availability of NE and DA at cortical sites (Faraone and Buitelaar, 2010),”
From Is autonomic nervous system function atypical in Attention Deficit Hyperactivity Disorder (ADHD)? A systematic review of the evidence (2020) · cites this paper as Faraone and Buitelaar, 2010
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Statistical Power Analysis for the Behavioral Sciences
Muller, K. (1989) · Technometrics · doi:10.1080/00401706.1989.10488618 · Cited by 99,167
Statistical power analysis for the behavioral sciences
(1990) · Computers, Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,269
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · cited 1×
“Our meta-analysis used the random effects model of DerSimonian and Laird [ 8 ].”
MethodThe meaning and use of the area under a receiver operating characteristic (ROC) curve.
Hanley, J. A., & McNeil, B. J. (1982) · Radiology · doi:10.1148/radiology.143.1.7063747 · Cited by 21,856
Statistical Methods for Meta-Analysis
Wasserman, S., Hedges, L. V., & Olkin, I. (1988) · Journal of Educational Statistics · doi:10.2307/1164953 · Cited by 10,326
Methods of Meta-Analysis: Correcting Error and Bias in Research Findings
Schmidt, F. L., & Hunter, J. E. (2015) · doi:10.4135/9781483398105 · Cited by 5,542
Statistical Methods for Meta-Analysis.
Freeman, P. R., Hedges, L. V., & Olkin, I. (1986) · Biometrics · doi:10.2307/2531069 · Cited by 4,784
(1967) · Project Euclid (Cornell University) · Cited by 4,720
Research works printed but not linked: 1
- Faraone SV, Sergeant J, Gillberg C, Biederman J (2003) The worldwide prevalence of ADHD: is it an American condition? World Psychiatry 2:104–113
Cited by
Items 301–400 of 485
Esperón, C. S., & Gómez, M. J. Á. (2013) · Revista de Neurología · doi:10.33588/rn.56s01.2013015 · Cited by 11
“El tamaño del efecto del metilfenidato de liberación inmediata es 0,91, y el del metilfenidato de liberación prolongada es 0,95 [3].”
BackgroundInfluentialCurrent Perspectives on Attention-deficit Hyperactivity Disorder
Shafiullah, S., & Dhaneshwar, S. S. (2023) · Current Molecular Medicine · doi:10.2174/1566524023666230522145950 · Cited by 13
Stimulants and Other Non-stimulants for Attention-Deficit/Hyperactivity Disorder (ADHD)
Markowitz, J. S., & Yu, G. (2016) · Springer eBooks · doi:10.1007/978-3-319-27883-4_12 · Cited by 9
Duric, N. S., Aßmus, J., Børresen, H., Golos, A. D., Sočanski, D., Duric, A., & Sürmeli, T. (2023) · Applied Neuropsychology Child · doi:10.1080/21622965.2023.2288865 · Cited by 8
“These differences in correlations might be attributed to the distinct interactions that parents and teachers have with their children (Arns et al., 2020; Faraone & Buitelaar, 2010), leading to varying perspectives on symptoms (Arns et al., 2020; Minder et al., 2018).”
An Infant with a Prolonged Sympathomimetic Toxidrome after Lisdexamfetamine Dimesylate Ingestion
Wood, K. E., & Krasowski, M. D. (2016) · Journal of Medical Toxicology · doi:10.1007/s13181-016-0560-x · Cited by 8
“well as by stimulating the transporters to work in reverse [9, 10].”
BackgroundElectroencephalogram Neurofeedback: Application in ADHD and Epilepsy
Mayer, K., & Arns, M. (2016) · Psychiatric Annals · doi:10.3928/00485713-20160906-01 · Cited by 7
Wagner, I. C., van Buuren, M., Bovy, L., Morris, R., & Fernández, G. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4502-8 · Cited by 8
“MPH is widely prescribed to alleviate symptoms of inattention and hyperactivity in attention-deficit/ hyperactivity disorder (Faraone and Buitelaar 2010; Wigal et al. 2011) and is used by healthy individuals to improve academic performance (Greely et al.”
BackgroundMethodAkay, A. P., Kaya, G. Ç., Köse, S., Yazıcıoğlu, Ç. E., Erkuran, H. Ö., Güney, S. A., Oğuz, K., Keskin, D., Baykara, B., İnal, N., et al. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.04.008 · Cited by 8
“Dopaminergic genes are considered important candidates for ADHD because they might create a basis for potent therapeutic effects of stimulants (Faraone and Buitelaar, 2010; Del Campo et al., 2011).”
BackgroundBiederman, J., Chan, J., Spencer, T. J., Woodworth, K. Y., Kenworthy, T., Fried, R., Bhide, P., & Faraone, S. V. (2015) · Journal of Brain Sciences · doi:10.18488/journal.83/2015.1.2/83.2.43.53 · Cited by 6
“While stimulants remain the mainstay of treatment for ADHD due to their large effect size [15-19], their effects on EF deficits (EFDs) in general and WM in particular are more equivocal [20].”
BackgroundSelf-citationSolomon, M. B., Yegla, B., Newcorn, J. H., Maletic, V., Rubin, J. S., & Robbins, T. W. (2025) · Clinical Drug Investigation · doi:10.1007/s40261-025-01473-4 · Cited by 11
“It is worth noting that on average the effect size for amphetamine in ADHD clinical trials is reportedly greater than for methylphenidate [253–256], but whether serotonergic effects are a contributing factor remains to be determined.”
Effects of Omega-3 Fatty Acids on Cognition and Behaviour in Childhood
Thornberg, U. B. (2011) · Cited by 6
Neuropsychological Effects of Placebo Stimulants in College Students
Lookatch, S. J., Fivecoat, H. C., & Moore, T. M. (2017) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2017.1344897 · Cited by 6
“The use of stimulant medication to reduce symptoms associated with ADHD is well-documented (Charach, Ickowicz, and Schachar 2004; Faraone and Buitelaar 2010).”
BackgroundTarakçıoğlu, M. C., Gökler, M. E., Kadak, M. T., Memik, N. Ç., & Aksoy, U. M. (2018) · Quality of Life Research · doi:10.1007/s11136-018-2086-y · Cited by 7
Dutta, C. N., Christov‐Moore, L., Ombao, H., & Douglas, P. K. (2022) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2022.938501 · Cited by 10
Kaiser, A., Aggensteiner, P.-M., Blasco-Fontecilla, H., Ros, T., Acquaviva, É., Attal, Y., Banaschewski, T., Baumeister, S., Bousquet, E., Bussalb, A., et al. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1331004 · Cited by 8
Elmaghraby, R., Pines, A. R., Geske, J. R., Coombes, B. J., Leung, J. G., Croarkin, P. E., Markota, M., & Bobo, W. V. (2024) · JAACAP Open · doi:10.1016/j.jaacop.2024.01.003 · Cited by 6
Walitza, S., Romanos, M., Warnke, A., Greenhill, L. L., & Gerlach, M. (2014) · Springer eBooks · doi:10.1007/978-3-7091-1501-5_8 · Cited by 7
Hautmann, C., Rothenberger, A., & Döpfner, M. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-219 · Cited by 7
“In randomized placebocontrolled trials, MPH has been shown to be effective and to be associated with, on average, large treatment effects [1,2].”
BackgroundIs There Long-Term Benefit From Stimulant Treatment for ADHD?
Pliszka, S. R. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.19070681 · Cited by 7
Maeder, J., Mancini, V., Sandini, C., Journal, F., Schneider, M., Kliegel, M., & Eliez, S. (2021) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyab057 · Cited by 7
“In idiopathic ADHD, extensive evidence shows that MPH medication significantly reduces core symptoms of ADHD compared with a placebo (Faraone and Buitelaar, 2010; Cortese et al., 2018).”
BackgroundAttention-Deficit/Hyperactivity Disorder
DuPaul, G. J., Pollack, B., & Pinho, T. D. (2017) · Springer eBooks · doi:10.1007/978-3-319-57196-6_20 · Cited by 5
D’Aiello, B., Vara, S. D., Rossi, P. D., Vicari, S., & Menghini, D. (2024) · PLoS ONE · doi:10.1371/journal.pone.0299449 · Cited by 9
Schwarz, N. F., Krafft, C. E., Chi, L., Weinberger, A. L., Schaeffer, D. J., Pierce, J. E., Rodrigue, A., Williams, C. F., DiBattisto, C., Maria, B. L., et al. (2015) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2015.10.003 · Cited by 5
“…provides a mechanism to increase CC-related fronto-striatal activation and has been shown to reduce symptoms of ADHD (Faraone and Biederman, 2002; Faraone and Buitelaar, 2010) and enhance cognitive and motor control (Kempton et al., 1999; Klein et al., 2002). journal homepage:…”
BackgroundAttention-Deficit Hyperactivity Disorder and Autism Spectrum Disorder
Cortese, S. (2016) · Springer eBooks · doi:10.1007/978-3-319-29695-1_6 · Cited by 6
Rubinson, M., Horowitz, I., Naim‐Feil, J., Gothelf, D., Moses, E., & Levit‐Binnun, N. (2019) · Brain Connectivity · doi:10.1089/brain.2018.0630 · Cited by 7
“Although MPH is considered an effective stimulant (Faraone and Buitelaar, 2010), the mechanisms underlying its efficacy remain unclear.”
Faraone, S. V., Childress, A. C., Goméni, R., Rafla, E., Kando, J. C., Dansie, L., Naik, P., & Pardo, A. (2023) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2022.0093 · Cited by 5
“This measure of effect can then be used to compare the efficacy of the treatment in question with similarly computed measures of treatment efficacy in other studies that may use seemingly noncomparable measures (Faraone and Buitelaar, 2010).”
MethodSelf-citationWalitza, S., Gerlach, M., Romanos, M., & Renner, T. (2016) · Springer eBooks · doi:10.1007/978-3-662-48624-5_8 · Cited by 7
Zhang, R., & Li, H. (2025) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-025-01924-w · Cited by 10
“Children suffering from ADHD are commonly prescribed stimulant medication as an effective treatment for reducing behavioural symptoms [7] and improve neurocognitive functioning [8].”
Baseline ImPACT Composite Scores in Student-Athletes With Attention-Deficit/Hyperactivity Disorder
Hrabarchuk, E. I., Hannah, T. C., Kalagara, R., Li, A. Y., Schüpper, A. J., McCarthy, L., Ali, M. A., Quinones, A., Gometz, A., Lovell, M. R., et al. (2023) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acad076 · Cited by 4
ADHD medication adherence reduces risk of committing minor offenses in adolescents
Rosenau, P. T., Dietrich, A., van den Hoofdakker, B. J., & Hoekstra, P. J. (2024) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.13997 · Cited by 6
Srinivas, C., Karlstad, Ø., Stigum, H., Furu, K., Cesta, C. E., Reutfors, J., Hutcheon, J. A., & Cohen, J. M. (2025) · Paediatric and Perinatal Epidemiology · doi:10.1111/ppe.70031 · Cited by 5
Wietecha, L. A., Wang, S., Saylor, K. E., Day, K. A., Wu, S. H., & Kelsey, D. (2014) · Clinical Pediatrics · doi:10.1177/0009922814555973 · Cited by 4
“In a 2010 meta-analysis of double-blind placebo-controlled studies, the response rate for the stimulant dexamphetamine was 88%, and the response rate for the stimulant methylphenidate was 79%.(1) A comparative study of the stimulants methylphenidate and amphetamine concluded that 87% of children with ADHD would respon…”
BackgroundAdult ADHD in Other Neurodevelopmental Disorders
Pallanti, S., & Salerno, L. (2020) · Springer eBooks · doi:10.1007/978-3-030-39051-8_7 · Cited by 4
Attention Deficit Hyperactivity Disorder
Marco, P., Maddalena, M., Bertella, S., Gatti, E., & Nobile, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00164-x · Cited by 5
Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung
Walitza, S., Renner, T., & Romanos, M. (2016) · Springer eBooks · doi:10.1007/978-3-662-48624-5_12 · Cited by 4
Childress, A. C., & Burton, S. M. (2022) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2022.2103406 · Cited by 5
“Although stimulant medications are very effective in improving ADHD symptoms, some patients may not respond, have problems with tolerability or prefer not to take a controlled substance [11,12].”
BackgroundAlexander, B., Lizeth, H., Huibert, D. M., & Linkenkaer‐Hansen, K. (2012) · InTech eBooks · doi:10.5772/24885 · Cited by 4
“…psychostimulant medication leads to a reduction of ADHD symptoms by increasing CNS arousal (Satterfield et al., 1974), but lacks long-term efficacy (Faraone & Buitelaar, 2010; Faraone & Glatt, 2010; Molina et al., 2009) and introduces adverse effects in 20-50% of the patients (Charach et al.,…”
Medicamentos estimulantes: uso e explicações em casos de crianças desatentas e hiperativas
Brzozowski, F. S., & Caponi, S. N. (2015) · Cadernos Brasileiros de Saúde Mental/Brazilian Journal of Mental Health · doi:10.5007/cbsm.v7i15.69013 · Cited by 11
Neurodevelopmental Disorders: Attention‐Deficit/Hyperactivity Disorder
Newcorn, J. H., Leikauf, J. E., Johnson, B., Krone, B., & Halperin, J. M. (2015) · Wiley eBooks · doi:10.1002/9781118753378.ch45 · Cited by 5
ADHD, a Food-Induced Hypersensitivity Syndrome: in Quest of a Cause.
Pelsser, L. M. J. (2011) · Wageningen University & Research Publications · Cited by 6
Vallerand, I. A., Kalenchuk, A. L., & McLennan, J. D. (2014) · Child and Adolescent Mental Health · doi:10.1111/camh.12062 · Cited by 5
Mutairi, A. N. H. A. (2015) · Journal of Child and Adolescent Behaviour · doi:10.4172/2375-4494.1000208 · Cited by 3
“Efficacy and safety of these drugs have been extensively examined in numerous clinical trials as well as in systematic reviews and meta-analyses [15-20].”
BackgroundAmphetamine extended-release oral suspension for attention-deficit/hyperactivity disorder
Childress, A. C., & Chow, H. (2019) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2019.1659723 · Cited by 3
Uebel, H., Dangel, O., Fischer, R., Ruhmann, M., & Huß, M. (2021) · Scandinavian Journal of Child and Adolescent Psychiatry and Psychology · doi:10.21307/sjcapp-2021-009 · Cited by 4
“Numerous randomized controlled trials (RCTs) and meta-analyses have demonstrated the efficacy and safety of stimulants for the treatment of ADHD in children and adolescents (8-12).”
BackgroundRaji, O., & Javaid, S. (2022) · British Journal of Learning Disabilities · doi:10.1111/bld.12446 · Cited by 4
The Treatment of Adult ADHD: Complexity at Hand
Pallanti, S., & Salerno, L. (2020) · Springer eBooks · doi:10.1007/978-3-030-39051-8_19 · Cited by 4
Davidson, F., Rigney, G., Rusak, B., Chambers, C. T., Rajda, M., & Corkum, P. V. (2020) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0000000000000866 · Cited by 4
Moghanloo, M., Aguilar‐Vafaie, M. E., Rostami, R., & Farahani, H. (2014) · NeuroRegulation · doi:10.15540/nr.1.2.131 · Cited by 2
Neurological Mechanisms of Diagnosis and Therapy in School Children with ADHD in Poland
Nermend, M., Flaga-Gieruszyńska, K., Kroplewski, Z., & Nermend, K. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19137615 · Cited by 6
“Another measure is behavioral therapy (as a type of psychotherapy), which is extremely supportive of the child’s functioning [23,24].”
BackgroundTranstorno de déficit de atenção/hiperatividade: o diagnóstico pode ser terapêutico?
Brzozowski, F. S., & Diehl, E. E. (2013) · Psicologia em Estudo · doi:10.1590/s1413-73722013000400008 · Cited by 16
“…efeitos considerados terapêuticos, devidos aos estimulantes, incluem redução da hiperatividade, da impulsividade e da falta de atenção e aumento de comportamentos relacionados, como manutenção do foco em uma tarefa, o desempenho acadêmico e escolar e as relações sociais (Faraone & Buitelaar, 2010).”
BackgroundGenetic factors and the brain in ADHD
Bralten, J. (2015) · Radboud Repository (Radboud University) · Cited by 32
Adler, L. A., Anbarasan, D., Sardoff, T., Leon, T. L., Gallagher, R., Massimi, C. A., & Faraone, S. V. (2024) · Journal of Attention Disorders · doi:10.1177/10870547231222260 · Cited by 2
“…prescribed medications to treat adult ADHD, with a recent meta-analysis indicating that, for adults, the efficacy/ tolerability tradeoff was better for amphetamine compared with methylphenidate (Cortese et al., 2018), which is consistent with data from studies of youth (Faraone & Buitelaar, 2010).”
ResultSelf-citationA pharmacotherapeutic and neuroimaging case study of maladaptive daydreaming
Mamah, D. T., Chen, S., Gomez-Lopez, A., & Alexander, S. (2025) · Psychiatry Research Case Reports · doi:10.1016/j.psycr.2025.100249 · Cited by 5
Cai, W., & Mizuno, Y. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-03972-0 · Cited by 5
James, J. E. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-802812-4.00015-1 · Cited by 3
Uytun, M. Ç., Çetin, F. H., & Babadağı, Z. (2019) · Psychiatry and Clinical Psychopharmacology · doi:10.1080/24750573.2019.1609153 · Cited by 4
“[MPH-ER], or osmotic release [OROS-MPH]) [9], and the effects of different preparations of MPH have been shown in meta-analyses [6,10].”
BackgroundPınar, Z. V., Çimen, İ. D., Tarakçıoğlu, M. C., & Gündoğdu, Ö. Y. (2022) · Çocuk ve Gençlik Ruh Sağlığı Dergisi / Turkish Journal of Child and Adolescent Mental Health · doi:10.4274/tjcamh.galenos.2021.44154 · Cited by 3
Hervig, M. E.-S., Toschi, C., Petersen, A., Vangkilde, S., Gether, U., & Robbins, T. W. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06269-4 · Cited by 2
“That AMPH has a higher degree of pro-attentional effects than MPH supports a meta-analysis of human studies arriving at the same conclusion (Faraone and Buitelaar 2010).”
ResultADHD, Distractibility, and ABA
Orantes, D., Rohacek, A., & Antshel, K. M. (2023) · Autism and child psychopathology series · doi:10.1007/978-3-031-27587-6_20 · Cited by 2
Bijl, D. (2019) · University of Regensburg Publication Server (University of Regensburg) · doi:10.5283/mnhd.16 · Cited by 2
Schwabe, U., & Fricke, U. (2012) · Springer eBooks · doi:10.1007/978-3-642-29242-2_2 · Cited by 3
Markowitz, J. S., & Brinda, B. J. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.939955 · Cited by 2
“Overall, based on the meta-analyses of effect sizes, it appears that AMP formulations may be moderately more efficacious than MPH products among children and adolescents and both tend to be more effective than available non-stimulants [12].”
BackgroundKlungsøyr, O., & Fredriksen, M. (2017) · Open Journal of Statistics · doi:10.4236/ojs.2017.76070 · Cited by 2
“Short term effect of medication for treatment of ADHD is well documented [3] [4] [5] [6].”
BackgroundTherapeutic response in children with ADHD: role of observers and settings
Bhat, V., Sengupta, S. M., Grizenko, N., & Joober, R. (2020) · World Journal of Pediatrics · doi:10.1007/s12519-019-00332-5 · Cited by 3
Pharmacological Treatment of ADHD
Yadav, P. (2020) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-7998-5495-1.ch008 · Cited by 2
Neurofeedback for ADHD: a Critical Review and Suggested Future Directions
Albert, J., Sánchez‐Carmona, A. J., Fernández‐Jaén, A., & López‐Martín, S. (2017) · Current Developmental Disorders Reports · doi:10.1007/s40474-017-0117-y · Cited by 8
Döpfner, M. (2018) · Springer eBooks · doi:10.1007/978-3-662-57369-3_27 · Cited by 3
A META-ANALYSIS OF PRESCRIPTION STIMULANT EFFICACY: ARE STIMULANTS NEUROCOGNITIVE ENHANCERS?
Marraccini, M. E. (2015) · Digital Commons - URI (University of Rhode Island) · doi:10.23860/diss-marraccini-marisa-2015 · Cited by 2
“…prostimulant medications for the reduction of Attention-Deficit/Hyperactivity Disorder (ADHD) symptomatology among adults and children has been well documented through clinical trials and metaanalyses (Faraone, 2012; Faraone & Biederman, 2002; Faraone & Buitelaar, 2010; Faraone and Glatt, 2010).”
BackgroundCommentary on Levy (2012) Politics vs practice: Withdrawal of the Draft NHMRC ADHD Guidelines
Starling, J. (2013) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412459570 · Cited by 2
“There are not only many short-term randomized controlled trials, particularly of the stimulants methylphenidate and dexamphetamine, but enough data for meta-analysis, not just for stimulants (Faraone and Buitelaar, 2010) but also for a more recent treatment, atomoxetine (Cheng et al.”
BackgroundMazzetti, C., ter Huurne, N., Buitelaar, J. K., & Jensen, O. B. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.13.990929 · Cited by 3
Self-citationHigh-Fat Diet and Psychiatric Disorders: What Is the Interplay?
Sethi, P., Chaudhary, T., Mishra, T., Prajapati, A., & Kumar, S. (2022) · Nutritional neurosciences · doi:10.1007/978-981-19-5021-6_16 · Cited by 1
Soufsaf, S., Robaey, P., & Nekka, F. (2023) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-023-09854-y · Cited by 2
Therapeutic Use of Dopamine Enhancers (Stimulants)
Zuddas, A., & Carucci, S. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_138-1 · Cited by 1
Dereschuk, K. J., Chen, P. S., & Espiridion, E. D. (2025) · Cureus · doi:10.7759/cureus.90386 · Cited by 2
“Stimulant medications, such as methylphenidate and amphetamine derivatives, are first-line treatments and have demonstrated efficacy in reducing ADHD symptoms [3].”
tDCS and neurofeedback in ADHD treatment
Bernadotte, A., & Zinchenko, O. O. (2025) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2025.1444283 · Cited by 5
Seward, M., Milligan, K., Sibalis, A., Wenban, H., & van Noordt, S. J. R. (2026) · Clinical EEG and Neuroscience · doi:10.1177/15500594251399706 · Cited by 1
Shim, J. K., Lee, S. I., Kim, S.-G., Ko, Y., Youn, H., & Lee, J. (2026) · Psychiatry Investigation · doi:10.30773/pi.2025.0283 · Cited by 3
“21 Low adherence to medication has been suggested as one of the potential causes of clinically significant residual symptoms despite medication treatment in adults with ADHD.”
Effects of atomoxetine and methylphenidate on quality of life and self-esteem in adults with ADHD
Lorenzo, R. D., Bonisoli, J., Gualtieri, F., Latella, E., Riguzzi, I., Ferri, P., & Rovesti, S. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1866964 · Cited by 1
Barkley, R. A. (2012) · The ADHD Report · doi:10.1521/adhd.2012.20.5.1 · Cited by 1
“Ever since physician Benjamin Feingold (1975) asserted that up to 70% of children with ADHD were so as a consequence of such food allergies or sensitivities, substantial research has been undertaken to explore this possibility.”
BackgroundChang, S. Y. (2014) · Springer eBooks · doi:10.1007/978-88-470-5322-9_125 · Cited by 2
Frölich, J., Breuer, D., Görtz‐Dorten, A., Amonn, F., Fischer, R., & Döpfner, M. (2013) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3182aa00ce · Cited by 1
Partain, P. I., White, J., & Hammerness, P. G. (2018) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000718 · Cited by 1
Attention-Deficit/Hyperactivity Disorder and Executive Dysfunction
Cook, N. E., & Forchelli, G. A. (2018) · Current clinical psychiatry · doi:10.1007/978-3-319-98643-2_8 · Cited by 3
Benzerlik ve farklılıklarıyla çocukluk çağında DEHB ve OSB: Bir gözden geçirme çalışması
Şen, G. (2020) · Erken Çocukluk Çalışmaları Dergisi · doi:10.24130/eccd-jecs.1967202041218 · Cited by 2
Reciprocal effects of single or repeated exposure to methylphenidate or sex in adult male rats
Pallikaras, V., Cionnaith, C. E. M., Rosales, V. C. F., Arvanitogiannis, A., & Pfaus, J. G. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06300-8 · Cited by 1
Wojciechowski, T. W. (2023) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000001743 · Cited by 2
Das, J., Biswal, J., Mohanty, R., Bose, M., & Parida, S. (2024) · Al-Rafidain Journal of Medical Sciences · doi:10.54133/ajms.v7i1.756 · Cited by 3
Aniracetam Ameliorates Attention Deficit Hyperactivity Disorder Behavior in Adolescent Mice
Sun, X.-L., Cui, J., Bai, H., Zhang, W., & Bai, W. (2025) · eNeuro · doi:10.1523/eneuro.0578-24.2025 · Cited by 3
Arun, M. (2015) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 1
Pérez, E. B., Beristaín, J. C. G., & Gutiérrez, R. H. (2018) · Salud Mental · doi:10.17711/sm.0185-3325.2018.040 · Cited by 1
Chen, Q., Larsson, H., Almqvist, C., Chang, Z., Lichtenstein, P., D'Onofrio, B. M., & Ludvigsson, J. F. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2211-7 · Cited by 1
Efficacy of Amphetamines, Methylphenidate, and Modafinil in the Treatment of Mental Disorders
Retz, W. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_319 · Cited by 1
An Analysis of the Interaction of Methylphenidate and Nicotine in Adolescent Rats: Effects on BDNF
Freeman, E. D. (2015) · Digital Commons - East Tennessee State University (East Tennessee State University) · Cited by 1
Medikamente zur Behandlung von ADHS
Benkert, O., & Hippius, H. (2012) · Springer eBooks · doi:10.1007/978-3-642-29810-3_10 · Cited by 1
Neurocognitive deficits in adult ADHD : preclinical and clinical studies
Tomlinson, A. (2014) · Research Explorer (The University of Manchester) · Cited by 1
When ADHD and substance use disorders coexist : etiology and pharmacological treatment
Skoglund, C. B. (2015) · Figshare · Cited by 1
Wat werkt bij jeugdigen met ADHD
Foolen, N., Kalsbeek, A., & Boendermaker, L. (2011) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 2
Fernández‐Jaén, A., Fernández-Mayoralas, D. M., Perrone, A. L. F., Pérez, B. C., Bitaubé, J. A., López‐Martín, S., & Arribas, S. L. (2016) · Revista de Neurología · doi:10.33588/rn.62s01.2015527 · Cited by 1
Pharmacological treatment and prognosis of ADHD
Elia, J., Kingsley, R. S., Lam, C., Takeda, T., de Berardinis, R., Laracy, S. D., Sackett, J. C., Tang, S.-C., Schardt, M., Nivus, K., et al. (2013) · doi:10.2217/ebo.13.229 · Cited by 1
Ghirardi, L. (2019) · Figshare · Cited by 1
Metadata
- Authors
- Faraone, S. V., & Buitelaar, J.
- Affiliations
- SUNY Upstate Medical University (US)
- Radboud University Nijmegen (NL)
- Corresponding author
- Faraone, Stephen V.
- Venue
- European Child & Adolescent Psychiatry
- Published
- 2009-09-10
- Volume
- 19
- Issue
- 4
- Pages
- 353-364
- ISSN
- 1018-8827 (ISSN-L)
- 1435-165X
- OpenAlex
- W2099805984
- Cited by
- 485
- References
- 54
- Citations by year
- 2026: 17 · 2025: 18 · 2024: 14 · 2023: 20 · 2022: 22 · 2021: 21 · 2020: 35 · 2019: 36 · 2018: 29 · 2017: 31 · 2016: 42 · 2015: 53 · 2014: 47 · 2013: 40 · 2012: 26
- FWCI
- 11.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- European Child & Adolescent Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Radboud Repository (Radboud University) (publishedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- Pfizer
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Social Sciences › Psychology › Developmental and Educational Psychology › Behavioral and Psychological Studies
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Keywords
- attention deficit hyperactivity disorder, stimulant medication, methylphenidate, amphetamine, drug efficacy comparison, placebo effect, hyperactivity, inattention, impulsivity, children and adolescents, dopamine signaling
- MeSH terms
- Adolescent, Adult, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Humans, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.